Seq_ID,Species,Phylogenetic lineage,Predicted drug resistance,Rifampicin,Isoniazid,Pyrazinamide,Ethambutol,Moxifloxacin,Amikacin,Cycloserine,Ethionamide,Kanamycin,Streptomycin,Capreomycin,Para-aminosalicylic acid,Clofazimine,Delamanid,Bedaquiline,Linezolid,Median genome coverage,Percentage reads mapped,Quality,Database version
O,Mycobacterium tuberculosis,Lineage 2,Pre-Extensive/Extensive drug-resistance predicted,rpoB_p.Ser450Leu (Resistant|High),fabG1_c.-15C>T (Low-level resistant|High);katG_p.Ser315Thr (Resistant|High),pncA_p.Gly132Ala (Resistant|High),embB_p.Gln497Arg (Resistant|High),gyrA_p.Asp94Gly (Resistant|High),No mechanism identified,No mechanism identified,fabG1_c.-15C>T (Resistant|High),No mechanism identified,rpsL_p.Lys43Arg (Resistant only in combination|High),No mechanism identified,No mechanism identified,No mechanism identified,fgd1_p.Val170Met (Resistant|Uncertain),No mechanism identified,No mechanism identified,195,98.86,Pass QC,tbtamr_2022-12-02
